Eyeworld

95 EW REFRACTIVE October 2018 Dr. Solomon said he discusses nanovision all the time with his patients who are seeking spectacle independence. "What I tell them is their distance vision will be a little worse, but it's in an effort to give them a better range of vision at intermediate and near. They're go- ing to have a little more haloing of lights with nanovision because you get that with a little bit of distance blur, but as long as they know that on the front end, they won't be as bothered by it. A lot of patients choose it," he said. Dr. Solomon said he also has positive outcomes with patients who have an EDOF lens in one eye and a multifocal, like the Tecnis 3.25 D, in the nondominant eye, allowing both eyes to be set to plano but the nondominant eye functioning at a slightly higher add for reading. Dr. Donnenfeld has taken this approach as well, but his preference is to use the same platform in both eyes. Like anyone being considered for a multifocal or EDOF lens, Dr. Solomon said he assesses the patient's personality, among other factors. "I don't do [nanovision] in type A patients or patients who are constantly going to compare one eye to the next, or anyone who is not an EDOF or multifocal candidate (those with irregular astigmatism, macular degeneration, diabetic retinopathy)," he said, adding that it is important to optimize the ocular surface, obtain accurate preoperative measurements, and optimize sur- geon factors. "It's going to be even more critical for the dominant eye that you hit plano because if both eyes are off target, patients aren't going to be as happy. In nanovision and monovision patients, it's critical to get the dominant eye on target for distance." EW References 1. Donnenfeld ED, et al. Visual acuity out- comes post-implantation of an extended depth of focus toric IOL targeted for emmetropia or nanovision. Paper presented at the 2018 ASCRS•ASOA Annual Meeting. 2. Slade SG, et al. Extended depth of focus (EDOF) toric IOL targeted for emmetropia in both eyes or nanovision: defocus curve and reading speed results. Paper presented at the 2018 ASCRS•ASOA Annual Meeting. 3. Sandoval H, et al. Visual and refractive clinical outcomes with a new extended depth of focus toric intraocular lens targeted for binocular emmetropia or slight myopia in the nondominant eye. Paper presented at the 2018 ASCRS•ASOA Annual Meeting. In the highly competitive optical field, you need to stand out in order to move forward. at's why the most successful practices turn to Partners In Vision. As a leader in Optical Dispensary Development + Management, we manage and grow your optical business through superior customer service, aention to detail, responsive inventory management and patient education. Let us be your team. Call for a free, no-risk assessment. PartnersInVision.com Since 1999 What are you doing to stand out in the crowd? O P T I C A L D I S P E N S A R Y M A N A G E M E N T 888.748.1112 Editors' note: Dr. Donnenfeld has financial interests with Johnson & Johnson Vision and Alcon (Fort Worth, Texas). Dr. Solomon has no financial interests related to his comments. Contact information Donnenfeld: ericdonnenfeld@gmail.com Solomon: kds@cepmd.com

• Cover